AstraZeneca, which is involved in developing the vaccine for deadly Covid 19 along with the University of Oxford has removed children from a mid-to-late stage trial of its COVID-19 vaccine in Britain, clinical trial registers in the United States showed on Monday.
The Previous trial of more than 12,000 participants included children above the age of five with the consent of their parents. But the trial data under the U.S. National Library of Medicine which was updated on Dec. 10 removed the sub-group including children. Other vaccine developers including Pfizer, Johnson & Johnson and Moderna are testing their vaccine candidates in children below 12 years to study how their vaccines work in a wider age group.
The different age group involvement in trials can help developers understand how their vaccines work in the larger population, but the U.S. Centers for Disease Control and Prevention said in October that kids may not be recommended for COVID-19 vaccination initially. AstraZeneca’s vaccine against the novel coronavirus produced a strong immune response in adults, a data published in November showed. AstraZeneca Vaccine candidate which runs ahead in the race has now been overtaken by Pfizer and its German partner BioNTech as well as Moderna in the race to develop a COVID-19 vaccine.
Oxford-Astrazeneca Corona vaccine may arrive in early 2021
India largest buyer of Covid 19, 1.6 billion doses to inoculate 800 million people